Health Condition 1: C530- Malignant neoplasm of endocervix
Conditions
Interventions
Intervention1: Group I: will receive 1.2 ml of 0.5 %(H) bupivacaine intrathecally
Control Intervention1: Group II: will receive 1.5 ml of 0.5 %(H) bupivacaine intrathecally
Sponsors
DRBRAIRCH AIIMS
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female patients in the age group 20 - 65 years belonging to ASA physical status I and ASA II scheduled for receiving intracavitary radiotherapy for carcinoma cervix. 2.Providing written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients allergic to local anaesthetic 2.Height less than 150 cm 3.Deranged coagulation profile 4. ASA status II or more
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| readiness to discharge after spinal anesthesiaTimepoint: sensory level every 5 minutes during the procedure and 15 minutes postoperatively till the deramatomal level is L5 (discharge criteria) After that the patient will be assessed for unaided walking to demonstrate motor recovery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.The highest level of sensory block and the degree of motor block achieved. 2.Hemodynamics will be recorded intraoperatively every 5 mins. 3.Post operatively the time taken for complete motor recoveryand time to sensory block recovery till S1 dermatome. 4.The satisfaction score graded by the operator and the patient using VAS from 0-10 at the end of the procedure. Timepoint: mentioned along with the objective | — |
Countries
India
Contacts
Public ContactNishkarsh gupta
DRBRAIRCH, AIIMS
Outcome results
None listed